Foyston, Gordon, & Payne’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-428,509
Closed -$15.2M 78
2016
Q2
$15.2M Sell
428,509
-24,043
-5% -$938K 2.77% 12
2016
Q1
$17.7M Buy
452,552
+13,614
+3% +$509K 3.3% 8
2015
Q4
$18.9M Buy
438,938
+81,518
+23% +$3.58M 3.56% 8
2015
Q3
$19.1M Sell
357,420
-113,082
-24% -$5.28M 3.55% 7
2015
Q2
$23.5M Sell
470,502
-21,106
-4% -$999K 3.53% 8
2015
Q1
$22.1M Sell
491,608
-2,088
-0.4% -$93.8K 3.27% 9
2014
Q4
$23.8M Buy
493,696
+2,365
+0.5% +$112K 3.4% 5
2014
Q3
$23.5M Sell
491,331
-50,031
-9% -$2.43M 3.38% 9
2014
Q2
$26.8M Buy
541,362
+10,920
+2% +$511K 3.41% 5
2014
Q1
$25M Buy
530,442
+30,747
+6% +$1.41M 3.08% 6
2013
Q4
$24M Sell
499,695
-27,435
-5% -$1.23M 2.98% 8
2013
Q3
$22.1M Sell
527,130
-50,681
-9% -$2.18M 2.88% 10
2013
Q2
$23.6M Buy
+577,811
New +$21.2M 3.51% 5

Other funds holding MET

Foyston, Gordon, & Payne's MET Position: Q3 2016 in Review

Foyston, Gordon, & Payne sold out of MetLife (MET) in Q3 2016, closing a stake of 428,509 shares — an estimated $15.2M sold.

Foyston, Gordon, & Payne first reported a position in MET in Q2 2013 and held it in 13 quarters. The position peaked at $26.8M in Q2 2014. 964 funds tracked by Wall St. Rank hold MET as of Q3 2016.

  • Foyston, Gordon, & Payne reported no remaining MetLife position as of Q3 2016 after selling out during the quarter.
  • Foyston, Gordon, & Payne sold 428,509 MetLife shares in Q3 2016, an estimated $15.2M.
  • Foyston, Gordon, & Payne first reported a position in MetLife in Q2 2013 and held it in 13 quarters.
  • Foyston, Gordon, & Payne's MetLife position peaked at $26.8M in Q2 2014.
  • 964 funds tracked by Wall St. Rank held MetLife as of Q3 2016.

Based on Foyston, Gordon, & Payne's 13F filing for Q3 2016, filed 14 Nov 2016.